Transel Pharmaceuticals (TDLP.OB) Appoints Terry Nida as CBO
Special topical pharmaceuticals company, Transdel Pharmaceuticals, Inc., announced today that it has appointed industry veteran Terry Nida as its Chief Business Officer. With over 30 years of pharmaceutical industry experience, Mr. Nida has an impressive track record in negotiating and closing global and regional joint development, licensing, distribution, sales and marketing partnerships and supply agreements with numerous pharmaceutical companies. Prior to joining Transel, Mr. Nida worked as an Executive Consultant for pharmaceutical and biotechnology companies. He held positions as Chief Operating Officer at Urigen Pharmaceuticals from 2006 to 2008 and Vice President Corporate Development, Marketing and Sales at VIVUS from…